Superworth

Amphastar Pharmaceuticals PE ratio AMPH

Share price divided by earnings per share over the last twelve months, since 2016.

Today, Nov 2, 2026
15.9×
10-year median
20.5×
Against its 10-year history
31st
percentile: 0 is its lowest day, 100 its highest
10-year range
7.5× to 448×
Peer median
12.0×

Amphastar Pharmaceuticals' PE ratio is 15.9× as of Nov 2, 2026: a share price of $27.03 against $1.70 of earnings per share over the last twelve months.

That is below its ten-year median of 20.5×, lower than on 69% of days in the last ten years.

Over that time it ranged from 7.5× in Jul 2025 to 448× in May 2019.

The median for 10 large drugmakers of a similar size is 12.0×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far15.9×8.9×16.3×
202512.0×7.5×12.3×
202412.6×12.6×24.5×
202324.2×19.4×35.1×
202218.8×15.5×47.6×
202132.3×27.7×419×
2020144×12.8×236×
201918.3×16.4×448×
2018209×207×221×
2017239×33.2×239×
201641.9×41.9×69.2×

Against its peers

Companies in Drug Manufacturers - General nearest Amphastar Pharmaceuticals' size, closest first, today.

Where Amphastar Pharmaceuticals ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Amphastar Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.